NCT03366506 Investigation of the Epidemiological Factors Associated With the Development of Amyotrophic Lateral Sclerosis (ALS)
| NCT ID | NCT03366506 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Hadassah Medical Organization |
| Condition | ALS |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2009-03-09 |
| Primary Completion | 2049-03 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2009-03-09 with a primary completion date of 2049-03.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Investigation of the epidemiological factors associated with amyotrophic lateral sclerosis (ALS) in Israel with a view to future international collaboration. Particularly addressing:- 1. Differences between ethnic subgroups 2. Differences between immigrant and native-born populations 3. Differences according to military service profile Clinical features gathered at each routine visit ,throughout the entire course of the disease, will be recorded in database format, in order to correlate with potential epidemiological factors.
Eligibility Criteria
Inclusion Criteria: \- Suspected, possible, probable ,definite ALS Exclusion Criteria: \-
Contact & Investigator
Marc Gotkine, MBBS
PRINCIPAL INVESTIGATOR
Hadassah Medical Organization
Frequently Asked Questions
Who can join the NCT03366506 clinical trial?
This trial is open to participants of all sexes, aged 12 Years or older, up to 120 Years, studying ALS. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT03366506 currently recruiting?
Yes, NCT03366506 is actively recruiting participants. Contact the research team at marc@gotkine.com for enrollment information.
Where is the NCT03366506 trial being conducted?
This trial is being conducted at Jerusalem, Israel.
Who is sponsoring the NCT03366506 clinical trial?
NCT03366506 is sponsored by Hadassah Medical Organization. The principal investigator is Marc Gotkine, MBBS at Hadassah Medical Organization. The trial plans to enroll 2,000 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.